Clinical Investigator
Joel GUIGAY, Pr
Gustave Roussy, Cancer Campus, Grand Paris
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
MIXED(2)
Methotrexate
1 trial
phase_3
gustave-roussy-cancer-campus-grand-parisCetuximab
1 trial
phase_3
gustave-roussy-cancer-campus-grand-paris2 unique interventions1 categories
Analytics
Trial Phases
Phase 31
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
Head Neck Cancer Squamous Cell Recurrent
StudychairStart date: 2013-11-06
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Gustave Roussy, Cancer Campus, Grand Paris
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Byoung Chul Cho, M.D., Ph.D.
Yonsei University
1 trials
Shared therapeutic areas:
Head Neck Cancer Squamous Cell Recurrent
Similarity Score30%
Byoung Chul Cho, M.D.,Ph.D.
Yonsei University
1 trials
Shared therapeutic areas:
Head Neck Cancer Squamous Cell Recurrent
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
Head Neck Cancer Squamous Cell Recurrent
All 1 trials loaded